Clinical Trial Update: An Observational Study Called FIRST-2.0 to Learn More About the Use of the Study Treatment Finerenone Including How Safe it is and How Well it Works Under Real-world Conditions

View source ↗

Summary

The FIRST-2.0 observational study evaluating finerenone for safety and effectiveness in real-world patients with chronic kidney disease and type 2 diabetes has …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• Type 2 Diabetes Mellitus

Drugs mentioned

• Finerenone (finerenone)

Snippet

Sponsor: Bayer | Conditions: Chronic Kidney Disease, Type 2 Diabetes Mellitus | Status: COMPLETED